Palatin Technologies

PTNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$18.273 M

$10.27 +0.49%

Close of 22 Sept 2026

Revenue

$0.00

#3637 by revenue

Earnings

$17.3M

#1917 by earnings

Shares outstanding

1,779,275

Latest filing cover page

P/E ratio

1.1

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#399Rocket OneRKTO$19.5M
#400Actuate TherapeuticsACTU$19.4M
#401Palatin TechnologiesPTN$18.3M
#402Jaguar HealthJAGX$17.9M
#403LipocineLPCN$17.8M

What if Palatin Technologies were worth as much as…

Open the what-if tool →

Gold $30.2T

$16,992,297

Per share 1,654,557× higher

Bitcoin $1.74T

$978,856.60

Per share 95,312× higher

Nvidia $5.52T

$3,100,008

Per share 301,851× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Palatin Technologies are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.